Non-profit DNDi preps phase 3 trials for dengue antibody
Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.
Bausch + Lomb drug fails in glaucoma, but a new use beckons
Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to abandon BL117 for glaucoma.
Roche abandons two Huntington's drug candidates
Roche has scrapped two drugs for Huntington's disease – tominersen and RG6496 – after seeing disappointing results in clinical trials.
Bayer gets €3bn from Apollo for contraceptives unit stake
Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.
Moderna's mResvia gets shot in the arm from EU contract
A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
The Evolution Summit Announces September 2026 Program for Cl...
Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA.
Register Now for AAPS PharmSci 360!
Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
16th World Clinical Biomarkers & CDx Summit
The globe’s longest-standing, industry-dedicated forum for precision medicine is back.
Inizio Launches Intelligent Congress to Turn Event Investmen...
Inizio, the leading global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress
17th World ADC San Diego | October 12-15, 2026
The World’s Premier Forum to Advance Differentiated ADCs to Redefine Early-Line Oncology Patient Outcomes